1.73
1.76%
0.03
Handel nachbörslich:
1.72
-0.01
-0.58%
Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
100.00%
-
|
0.659 | 1.185 | 2.004 | 5.313 |
Operating Expenses
|
19.24%
18.23
|
22.57 | 20.69 | 20.49 | 20.83 |
Operating Income/Loss |
16.81%
-18.23
|
-21.91 | -19.50 | -18.49 | -15.52 |
Nonoperating Income/Loss |
2.107
|
- | 2.16 | 1.375 | 1.296 |
Income/Loss From Continuing Operations Before Tax |
17.97%
-16.12
|
-19.65 | 1.185 | -17.11 | -14.22 |
Income Tax Expense/Benefit |
0.027
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
17.15%
-16.15
|
-19.49 | -17.34 | -17.11 | -14.22 |
Net Income/Loss
|
17.15%
-16.15
|
-19.49 | -17.34 | -17.11 | -14.22 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,259%
48.26
|
2.0461 | 43.44 | 39.29 | 36.26 |
Diluted Average Shares |
2,259%
48.26
|
2.0461 | 43.44 | 39.29 | 36.26 |
Basic Earnings Per Share |
17.50%
-0.33
|
-0.40 | -0.40 | -0.44 | -0.39 |
Diluted Earnings Per Share |
17.50%
-0.33
|
-0.40 | -0.40 | -0.44 | -0.39 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):